Skip to main content
Top
Published in: World Journal of Urology 2/2004

01-06-2004 | Free Paper

Effect of keratinocyte growth factor and activin on cell growth in the human prostatic cancer cell line LNCaP

Authors: Bernhard Planz, Horia Oltean, Thomas Deix, Sandra D. Kirley, Qi Fa Wang, W. S. McDougal, Michael Marberger

Published in: World Journal of Urology | Issue 2/2004

Login to get access

Abstract

Keratinocyte growth factor (KGF) has paracrine properties in the human prostate which stimulate epithelial cell growth. Activins have profound effects on cell growth and function in the human prostate, and are expressed in LNCaP, DU 145 and PC3 cells. LNCaP cells were characterized by immuncytochemistry, an immunoassay and polymerase chain reaction. A 3[H]thymidine assay was used with 0.01–10 nM dihydrotestosterone, 10 µM flutamide, 1–100 ng/ml KGF and 3 nM activin. LNCaP cells expressed Ki67, PSA, cytokeratins (8, 18, 19, 14, 15) androgenreceptor but no KGF protein. LNCaP cells showed telomerase activity. Furthermore, ARmRNA (365 bp), but no KGF or KGFRmRNA were expressed. KGF ELISA detected no intracellular or secreted KGF. DHT (1, 10 and 100 nM) and KGF (10 and 100 ng/ml) significantly stimulated LNCaP cell proliferation. However, flutamide and 3 nM activin A significantly decreased cell proliferation in the presence and absence of KGF. The results of our experiments support the hypothesis that cell growth and proliferative characteristics of LNCaP cells are modulated by KGF and activin A.
Literature
1.
go back to reference Culig Z, Hobisch A, Cronauer MV, Hittmair A, Radmayr C, Bartsch G, Klocker H (1994) Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor and epidermal growth factor. Cancer Res 54:5474–5478PubMed Culig Z, Hobisch A, Cronauer MV, Hittmair A, Radmayr C, Bartsch G, Klocker H (1994) Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor and epidermal growth factor. Cancer Res 54:5474–5478PubMed
2.
go back to reference Culig Z, Hobisch A, Cronauer MV, Hittmair A, Radmayr C, Bartsch G, Klocker H (1995) Activation of the androgen receptor by polypeptide growth factors and cellular regulators. World J Urol 13: 285–289PubMed Culig Z, Hobisch A, Cronauer MV, Hittmair A, Radmayr C, Bartsch G, Klocker H (1995) Activation of the androgen receptor by polypeptide growth factors and cellular regulators. World J Urol 13: 285–289PubMed
3.
go back to reference Dahiya R, Lee C, Haughney PC, Chui HR, Deng G (1996) Differential gene expression of transforming growth factor, keratinocyte growth factor, and their receptors in fetal and adult human prostatic tissues and cancer cell lines. Urology 48: 963–970 Dahiya R, Lee C, Haughney PC, Chui HR, Deng G (1996) Differential gene expression of transforming growth factor, keratinocyte growth factor, and their receptors in fetal and adult human prostatic tissues and cancer cell lines. Urology 48: 963–970
4.
go back to reference De Paulo LV, Bicsak TA, Erickson GF, Shimasaki S, Ling N (1991) Follistatin and activin: a potential intrinsic regulatory system within diverse tissues. Proc Soc Exp Biol Med 198:500–512PubMed De Paulo LV, Bicsak TA, Erickson GF, Shimasaki S, Ling N (1991) Follistatin and activin: a potential intrinsic regulatory system within diverse tissues. Proc Soc Exp Biol Med 198:500–512PubMed
5.
go back to reference Di Loreto C, Reis FM, Cataldi P, Zuiani C, Luisi S, Beltrami CA, Petraglia F (1999) Human mammary gland and breast carcinoma contain immunoreactive inhibin/activin subunits: evidence for a secretion into cystic fluid. Eur J Endocrinol 141:190–194 Di Loreto C, Reis FM, Cataldi P, Zuiani C, Luisi S, Beltrami CA, Petraglia F (1999) Human mammary gland and breast carcinoma contain immunoreactive inhibin/activin subunits: evidence for a secretion into cystic fluid. Eur J Endocrinol 141:190–194
6.
go back to reference Fasciana C, Van der Made AC, Faber PW, Trapman J (1996) Androgen regulation of the rat keratinocyte growth actor (KGF/FGF7) promoter. Biochem Biophys Res Commun 220: 858–863CrossRefPubMed Fasciana C, Van der Made AC, Faber PW, Trapman J (1996) Androgen regulation of the rat keratinocyte growth actor (KGF/FGF7) promoter. Biochem Biophys Res Commun 220: 858–863CrossRefPubMed
7.
go back to reference Finch PW, Rubin JS, Miki T et al. (1989) Human KGF is FGF related with properties of a paracrine effector of epithelial cell growth. Science 245:752PubMed Finch PW, Rubin JS, Miki T et al. (1989) Human KGF is FGF related with properties of a paracrine effector of epithelial cell growth. Science 245:752PubMed
8.
go back to reference Horoszewicz JS, Leong SS, Kawinski E, Karr J, Rosenthal H, Chu TM, Mirand EA, Murphy GP (1983) LNCaP model of human prostatic carcinoma. Cancer Res 43:1809–1818PubMed Horoszewicz JS, Leong SS, Kawinski E, Karr J, Rosenthal H, Chu TM, Mirand EA, Murphy GP (1983) LNCaP model of human prostatic carcinoma. Cancer Res 43:1809–1818PubMed
9.
go back to reference Ittman M, Mansukhani A (1997) Expression of fibroblast growth factors (FGFs) and FGF receptors in human prostate. J Urol 157:351CrossRefPubMed Ittman M, Mansukhani A (1997) Expression of fibroblast growth factors (FGFs) and FGF receptors in human prostate. J Urol 157:351CrossRefPubMed
10.
go back to reference Kuratsukuri K, Sugimura K, Harimoto K, Kawashima H, Kishimoto T (1999) “Decoy” of androgen-responsive element induces apoptosis in LNCaP cells. Prostate 41: 121–126CrossRefPubMed Kuratsukuri K, Sugimura K, Harimoto K, Kawashima H, Kishimoto T (1999) “Decoy” of androgen-responsive element induces apoptosis in LNCaP cells. Prostate 41: 121–126CrossRefPubMed
11.
go back to reference Leung HY, Mehta P, Gray LB et al. (1997) Keratinocyte growth factor expression in hormone insensitive prostate cancer. Oncogene 15:1115CrossRefPubMed Leung HY, Mehta P, Gray LB et al. (1997) Keratinocyte growth factor expression in hormone insensitive prostate cancer. Oncogene 15:1115CrossRefPubMed
12.
go back to reference Lin MF, Lee MS, Garcia-Arenas R, Lin FF (2000) Differential responsiveness of prostatic acid phosphatase and prostate-specific antigen mRNA to androgen in prostate cancer cells. Cell Biol Int 24: 681–689CrossRefPubMed Lin MF, Lee MS, Garcia-Arenas R, Lin FF (2000) Differential responsiveness of prostatic acid phosphatase and prostate-specific antigen mRNA to androgen in prostate cancer cells. Cell Biol Int 24: 681–689CrossRefPubMed
13.
go back to reference Nishihara T, Okahashi N, Ueda N (1993) Activin A induces apoptotic cell death. Biochem Biophys Res Commun 197:985–991CrossRefPubMed Nishihara T, Okahashi N, Ueda N (1993) Activin A induces apoptotic cell death. Biochem Biophys Res Commun 197:985–991CrossRefPubMed
14.
go back to reference Planz B, Wang QF, Kirley SD et al. (1998) Androgen responsiveness of stromal cells of the human prostate: regulation of cell proliferation and keratinocyte growth factor by androgen. J Urol 160:1850CrossRefPubMed Planz B, Wang QF, Kirley SD et al. (1998) Androgen responsiveness of stromal cells of the human prostate: regulation of cell proliferation and keratinocyte growth factor by androgen. J Urol 160:1850CrossRefPubMed
15.
go back to reference Planz B, Aretz HT, Wang QF, Tabatabaei S, Kirley SD et al. (1999) Immunolocalisation of the keratinocyte growth factor in benign and neoplastic human prostate and its relation to androgen receptor. Prostate 41:233–242CrossRefPubMed Planz B, Aretz HT, Wang QF, Tabatabaei S, Kirley SD et al. (1999) Immunolocalisation of the keratinocyte growth factor in benign and neoplastic human prostate and its relation to androgen receptor. Prostate 41:233–242CrossRefPubMed
16.
go back to reference Rubin JS, Osada H, Finch PW et al. (1989) Purification and characterization of newly identified growth factor specific for epithelial cells. Proc Natl Acad Sci U S A 86:802PubMed Rubin JS, Osada H, Finch PW et al. (1989) Purification and characterization of newly identified growth factor specific for epithelial cells. Proc Natl Acad Sci U S A 86:802PubMed
17.
go back to reference Sanger F, Nicklen S, Coulson AR (1977) DNA-sequencing with chain terminating inhibitors. Proc Natl Acad Sci U S A 74:5463PubMed Sanger F, Nicklen S, Coulson AR (1977) DNA-sequencing with chain terminating inhibitors. Proc Natl Acad Sci U S A 74:5463PubMed
18.
go back to reference Taplin ME, Bubley GJ, Shuster TD et al. (1995) Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer. N Engl J Med 332:1393 Taplin ME, Bubley GJ, Shuster TD et al. (1995) Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer. N Engl J Med 332:1393
19.
go back to reference Thomas TZ, Wang H, Niclasen P, O’Bryan MK, Evans LW, Groome NP, Pedersen J, Risibridger GP (1997) Expression and localisation of activin subunits and follistatins in tissues from men with high grade prostate cancer. J Clin Endocrinol Metab 82:3851–1858PubMed Thomas TZ, Wang H, Niclasen P, O’Bryan MK, Evans LW, Groome NP, Pedersen J, Risibridger GP (1997) Expression and localisation of activin subunits and follistatins in tissues from men with high grade prostate cancer. J Clin Endocrinol Metab 82:3851–1858PubMed
20.
go back to reference Wang QF, Tabatabaei S, Planz B, Lin CW, Sluss PM (1999) Identification of an activin-folistatin growth modulatory system in the human prostate: secretion and biological activity in primary cultures of prostatic epithelial cells. J Urol 161:1378–1384PubMed Wang QF, Tabatabaei S, Planz B, Lin CW, Sluss PM (1999) Identification of an activin-folistatin growth modulatory system in the human prostate: secretion and biological activity in primary cultures of prostatic epithelial cells. J Urol 161:1378–1384PubMed
Metadata
Title
Effect of keratinocyte growth factor and activin on cell growth in the human prostatic cancer cell line LNCaP
Authors
Bernhard Planz
Horia Oltean
Thomas Deix
Sandra D. Kirley
Qi Fa Wang
W. S. McDougal
Michael Marberger
Publication date
01-06-2004
Publisher
Springer-Verlag
Published in
World Journal of Urology / Issue 2/2004
Print ISSN: 0724-4983
Electronic ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-003-0391-7

Other articles of this Issue 2/2004

World Journal of Urology 2/2004 Go to the issue